Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20081
20101
20131
20161
20201
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status4
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Asan Medical Center1
European Institute of Oncology1
Kyung Hee University Hospital at Gangdong1
Kyungpook National University Hospital1
Merck Sharp & Dohme LLC1
Mirati Therapeutics Inc.1
National Cancer Center, Korea1
National Cancer Centre, Singapore1
Nova Scotia Health Authority1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms12
Colonic Neoplasms6
Colorectal Neoplasms5
Colonic Diseases1
Digestive System Diseases1
Digestive System Neoplasms1
Gastrointestinal Diseases1
Gastrointestinal Neoplasms1
Intestinal Diseases1
Intestinal Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.